arrow
K

Kenichi Suda

kindai university (kinki university)
H指数:40
被引数:5,821

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study

抗生素和质子泵抑制剂对局部晚期非小细胞肺癌术前化免疫疗法疗效无影响:一项多中心回顾性研究

2026-02-260
PRE
Corrigendum to “The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423–1440]”

勘误表:“国际肺癌研究协会分期项目:常见分子改变对IASLC第九版分期数据库初始分析中NSCLC总生存期的影响”。[胸腔肿瘤学杂志 卷20 期10:1423–1440]

2025-11-010
PRE
Safety Profile of Neoadjuvant Chemoimmunotherapy with Nivolumab for Patients with Resectable NSCLC in the Real-world (CReGYT-04 Neo-Venus)

纳武利尤单抗新辅助化免疫疗法在可切除非小细胞肺癌患者中的真实世界安全性分析 (CReGYT-04 Neo-Venus)

2025-10-300
PRE
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database

国际肺癌研究协会分期项目:在IASLC第九版分期数据库的初步分析中,常见分子改变对非小细胞肺癌总生存期的影响

2025-09-080
PRE
Adjuvant therapy in pStage IA1–IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study)

pStage IA1–IIA期肺腺癌(pN0)的辅助治疗:一项聚焦于EGFR突变和复发模式的多中心研究(CReGYT-01 EGFR研究)

2025-07-170
PRE
Clinical Utility of the 5-Point Visual Deauville Score for Preoperative Evaluation in Stage I NSCLC: A Multicenter Retrospective Study

5点视觉多维尔评分在术前评估Ⅰ期非小细胞肺癌中的临床应用价值:一项多中心回顾性研究

2025-07-160
PRE
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study)
2024-11-211
PRE
Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study
2024-04-011
PRE
Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

手术切除的肺癌患者来源的类器官作为生物标志物和药物测试的体外模型的临床相关性

2023-09-014
OA
Expert consensus on perioperative treatment for non-small cell lung cancer

非小细胞肺癌围手术期治疗专家共识

2022-07-0110
OAAI